Syracuse University is a private research university in Syracuse, New York. Established in 1870 with roots in the Methodist Episcopal Church, the university has been nonsectarian since 1920.

During the past decade, Syracuse University conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Syracuse University" #1 sponsor was "Syracuse University" with 12 trials, followed by "New York University" with 3 trials sponsored, "Avanir Pharmaceuticals" with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "The Miriam Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Syracuse University" #1 collaborator was "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 5 trials as a collaborator, "Syracuse University" with 5 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 4 trials as a collaborator, "Montclair State University" with 3 trials as a collaborator and "Auburn University" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Syracuse University" are "Alcohol Drinking" (4 trials), "Speech Sound Disorder" (3 trials), "Pain" (2 trials), "Stroke" (2 trials) and "Acute Pain" (1 trials). Many other conditions were trialed in "Syracuse University" in a lesser frequency.

Most popular intervention types in "Syracuse University" are "Behavioral" (14 trials), "Drug" (4 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Visual-acoustic biofeedback" (2 trials), "3-month radio intervention on infant vaccination" (1 trials), "AVP-923" (1 trials), "Active transcranial direct current stimulation (tDCS)" (1 trials) and "Alcohol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Syracuse University" are 20 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Syracuse University". 1 are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Syracuse University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Syracuse University, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".